Asset Management One
AGIO icon

Asset Management One’s Agios Pharmaceuticals AGIO Stock Holding History

Asset Management One’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,059
Closed -$597K – 1029
2020
Q3 		$597K Buy
17,059
+6,196
+57% +$272K ﹤0.01% 891
2020
Q2 		$581K Hold
10,863
– – ﹤0.01% 878
2020
Q1 		$385K Hold
10,863
– – ﹤0.01% 904
2019
Q4 		$519K Hold
10,863
– – ﹤0.01% 940
2019
Q3 		$352K Hold
10,863
– – ﹤0.01% 966
2019
Q2 		$542K Hold
10,863
– – ﹤0.01% 957
2019
Q1 		$733K Hold
10,863
– – ﹤0.01% 916
2018
Q4 		$487K Hold
10,863
– – ﹤0.01% 944
2018
Q3 		$827K Hold
10,863
– – ﹤0.01% 927
2018
Q2 		$900K Hold
10,863
– – ﹤0.01% 940
2018
Q1 		$888K Hold
10,863
– – ﹤0.01% 893
2017
Q4 		$659K Sell
10,863
-37,248
-77% -$2.34M ﹤0.01% 919
2017
Q3 		$3.13M Hold
48,111
– – 0.01% 803
2017
Q2 		$2.52M Buy
48,111
+5,308
+12% +$271K 0.01% 774
2017
Q1 		$2.45M Buy
42,803
+6,246
+17% +$299K 0.01% 774
2016
Q4 		$1.56M Sell
36,557
-34,473
-49% -$1.81M ﹤0.01% 788
2016
Q3 		$3.68M Buy
71,030
+37,336
+111% +$1.63M 0.05% 411
2016
Q2 		$1.5M Sell
33,694
-21,144
-39% -$1.04M 0.02% 717
2016
Q1 		$2.08M Buy
54,838
+7,215
+15% +$308K 0.03% 611
2015
Q4 		$3.21M Buy
47,623
+657
+1% +$43.1K 0.05% 448
2015
Q3 		$3.21M Sell
46,966
-4,197
-8% -$410K 0.05% 459
2015
Q2 		$5.34M Sell
51,163
-7,637
-13% -$823K 0.07% 348
2015
Q1 		$5.81M Buy
58,800
+27,150
+86% +$3.04M 0.07% 347
2014
Q4 		$3.66M Buy
+31,650
New +$2.83M 0.05% 503

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Asset Management One's AGIO Position: Q4 2020 in Review

Asset Management One sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 17,059 shares — an estimated $597K sold.

Asset Management One first reported a position in AGIO in Q4 2014 and held it in 24 quarters. The position peaked at $5.81M in Q1 2015. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Asset Management One reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Asset Management One sold 17,059 Agios Pharmaceuticals shares in Q4 2020, an estimated $597K.
  • Asset Management One first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 24 quarters.
  • Asset Management One's Agios Pharmaceuticals position peaked at $5.81M in Q1 2015.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Asset Management One's 13F filing for Q4 2020, filed 12 Feb 2021.